Immune Complexes in Juvenile Idiopathic Arthritis

Area of Science:

• Immunology
• Pediatric Rheumatology
• Autoimmune Diseases

Background:

• Juvenile idiopathic arthritis (JIA) is a heterogeneous autoimmune disorder in children.
• Elevated circulating immune complexes (CICs) and complement activation by-products are hallmarks of JIA.
• Immune complexes (ICs) are detected in up to 75% of JIA patients using various methods.

Purpose of the Study:

• To review existing literature on CICs in JIA.
• To discuss the role of protein modification in immune response generation within JIA.
• To explore the involvement of ICs in ectopic germinal center development and potential therapeutic strategies for JIA.

Main Methods:

• Detection of ICs in JIA patient sera using multiple techniques (e.g., affinity columns, solid-phase assays, precipitation methods).
• Analysis of the CIC proteome in JIA patients, including peptide fragment identification via SDS-PAGE and 2-DE.
• Detection of various components within ICs, such as rheumatoid factor (RF) isotypes, anti-CCP antibodies, IgG, complement factors (C1q, C4, C3), and the membrane attack complex (MAC).

Main Results:

• Multiple peptide fragments were identified within ICs from JIA patients.
• All tested immunoglobulin isotypes, RF, anti-CCP antibodies, complement components, and MAC were found in JIA-associated ICs.
• Complement activation and IC levels correlate with JIA disease activity.

Conclusions:

• ICs play a significant role in the pathophysiology of JIA.
• Understanding ICs and associated protein modifications may elucidate JIA pathogenesis, including ectopic germinal center formation.
• ICs in JIA represent potential targets for novel therapeutic interventions.